TrialThe oncologist2021

Effectiveness of Alpelisib + Fulvestrant Compared with Real-World Standard Treatment Among Patients with HR+, HER2-, PIK3CA-Mutated Breast Cancer.

Stuart Turner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.